Beranda2096 • HKG
add
Simcere Pharmaceutical Group Ltd
Tutup sebelumnya
$8,76
Rentang hari
$8,68 - $9,11
Rentang tahun
$5,08 - $9,11
Kapitalisasi pasar
22,35Â M HKD
Volume Rata-Rata
7,58Â jt
Rasio P/E
28,95
Hasil dividen
1,91%
Bursa utama
HKG
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,76Â M | 9,08% |
Biaya operasional | 1,15Â M | 11,53% |
Laba bersih | 138,28Â jt | 117,73% |
Margin laba bersih | 7,85 | 116,25% |
Penghasilan per saham | — | — |
EBITDA | 330,12Â jt | 44,43% |
Tarif pajak efektif | 14,95% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,94Â M | -3,73% |
Total aset | 11,51Â M | 6,05% |
Total liabilitas | 4,44Â M | 22,33% |
Total ekuitas | 7,07 M | — |
Saham yang beredar | 2,47 M | — |
Harga terhadap nilai buku | 3,06 | — |
Tingkat pengembalian aset | 6,01% | — |
Tingkat pengembalian modal | 8,35% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 138,28Â jt | 117,73% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The Company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
CEO
Didirikan
1995
Kantor pusat
Situs
Karyawan
6.584
